{"id":"W2033163507","doi":"10.1016/j.clinthera.2013.12.011","title":"Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Pfizer","keywords":"Apixaban; Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Stroke (engine); Discontinuation; Cost effectiveness; Randomized controlled trial; Quality-adjusted life year; Warfarin; Quality of life (healthcare); Internal medicine; Intensive care medicine; Cardiology; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521246,0.0001104915,0.0005387314,0.00008014901,0.00002142816,0.00001029421,0.00005580076,0.0001603793,0.00002847648],"category_scores_gemma":[0.0005033155,0.00009519599,0.0004043528,0.0001226132,0.00004930768,0.00005728878,0.00002104786,0.00008032144,0.000009682895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002966649,"about_ca_system_score_gemma":0.00005906333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001028215,"about_ca_topic_score_gemma":0.0000128645,"domain_scores_codex":[0.9985943,0.0003009428,0.000589296,0.0001976971,0.0001666258,0.0001511455],"domain_scores_gemma":[0.9973349,0.002135369,0.0002068779,0.0001969417,0.00006686379,0.00005905502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01366263,0.0000215581,0.7327172,0.0001047616,0.0003779319,1.745143e-7,0.00002893284,0.0004776395,0.0004326343,0.002137512,0.0000276703,0.2500114],"study_design_scores_gemma":[0.05589091,0.00304358,0.8090014,0.0002430618,0.001090231,5.27453e-7,0.00004100072,0.02190297,0.001319592,0.004054902,0.1031209,0.0002908074],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9466023,0.0001387583,0.04868535,0.0004378431,0.001512722,0.002163872,0.000009021941,0.00004166361,0.0004084569],"genre_scores_gemma":[0.9946026,0.00008708311,0.002675523,0.00006994997,0.001847962,0.000001402534,0.00003832199,0.00002329025,0.0006538236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2497206,"threshold_uncertainty_score":0.388198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4687215229406663,"score_gpt":0.5252876808651197,"score_spread":0.05656615792445335,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}